These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 21978603)

  • 41. Imaging axonal damage of normal-appearing white matter in multiple sclerosis.
    Fu L; Matthews PM; De Stefano N; Worsley KJ; Narayanan S; Francis GS; Antel JP; Wolfson C; Arnold DL
    Brain; 1998 Jan; 121 ( Pt 1)():103-13. PubMed ID: 9549491
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence of axonal damage in cerebellar peduncles without T2-lesions in multiple sclerosis.
    Hannoun S; Kocevar G; Durand-Dubief F; Stamile C; Naji A; Cotton F; Cavallari M; Guttmann CRG; Sappey-Marinier D
    Eur J Radiol; 2018 Nov; 108():114-119. PubMed ID: 30396642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MRI mean diffusivity detects widespread brain degeneration in multiple sclerosis.
    Senda J; Watanabe H; Tsuboi T; Hara K; Watanabe H; Nakamura R; Ito M; Atsuta N; Tanaka F; Naganawa S; Sobue G
    J Neurol Sci; 2012 Aug; 319(1-2):105-10. PubMed ID: 22626631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis.
    Parry A; Clare S; Jenkinson M; Smith S; Palace J; Matthews PM
    J Neurol; 2002 Sep; 249(9):1279-86. PubMed ID: 12242554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Longitudinal changes in diffusion tensor-based quantitative MRI in multiple sclerosis.
    Harrison DM; Caffo BS; Shiee N; Farrell JA; Bazin PL; Farrell SK; Ratchford JN; Calabresi PA; Reich DS
    Neurology; 2011 Jan; 76(2):179-86. PubMed ID: 21220722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Imaging G-Ratio in Multiple Sclerosis Using High-Gradient Diffusion MRI and Macromolecular Tissue Volume.
    Yu F; Fan Q; Tian Q; Ngamsombat C; Machado N; Bireley JD; Russo AW; Nummenmaa A; Witzel T; Wald LL; Klawiter EC; Huang SY
    AJNR Am J Neuroradiol; 2019 Nov; 40(11):1871-1877. PubMed ID: 31694819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multimodal MRI Response to Fingolimod in Multiple Sclerosis: A Nonrandomized, Single Arm, Observational Study.
    Bernitsas E; Kopinsky H; Lichtman-Mikol S; Razmjou S; Santiago-Martinez C; Yarraguntla K; Bao F
    J Neuroimaging; 2021 Mar; 31(2):379-387. PubMed ID: 33368776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atlas-based investigation of human brain tissue microstructural spatial heterogeneity and interplay between transverse relaxation time and radial diffusivity.
    Walimuni IS; Hasan KM
    Neuroimage; 2011 Aug; 57(4):1402-10. PubMed ID: 21658457
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative texture analysis of brain white matter lesions derived from T2-weighted MR images in MS patients with clinically isolated syndrome.
    Loizou CP; Petroudi S; Seimenis I; Pantziaris M; Pattichis CS
    J Neuroradiol; 2015 Apr; 42(2):99-114. PubMed ID: 24970463
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deep learning with diffusion basis spectrum imaging for classification of multiple sclerosis lesions.
    Ye Z; George A; Wu AT; Niu X; Lin J; Adusumilli G; Naismith RT; Cross AH; Sun P; Song SK
    Ann Clin Transl Neurol; 2020 May; 7(5):695-706. PubMed ID: 32304291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis.
    Oh J; Zackowski K; Chen M; Newsome S; Saidha S; Smith SA; Diener-West M; Prince J; Jones CK; Van Zijl PC; Calabresi PA; Reich DS
    Mult Scler; 2013 Apr; 19(4):427-35. PubMed ID: 22891033
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential changes in deep and cortical gray matters of patients with multiple sclerosis: a quantitative magnetic resonance imaging study.
    Zhou F; Zee CS; Gong H; Shiroishi M; Li J
    J Comput Assist Tomogr; 2010; 34(3):431-6. PubMed ID: 20498549
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterizing Microstructural Tissue Properties in Multiple Sclerosis with Diffusion MRI at 7 T and 3 T: The Impact of the Experimental Design.
    De Santis S; Bastiani M; Droby A; Kolber P; Zipp F; Pracht E; Stoecker T; Groppa S; Roebroeck A
    Neuroscience; 2019 Apr; 403():17-26. PubMed ID: 29631021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
    Deppe M; Marinell J; Krämer J; Duning T; Ruck T; Simon OJ; Zipp F; Wiendl H; Meuth SG
    Neuroimage Clin; 2014; 6():475-87. PubMed ID: 25610761
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of multiple sclerosis lesions with distinct clinical correlates through quantitative diffusion MRI.
    Martínez-Heras E; Solana E; Prados F; Andorrà M; Solanes A; López-Soley E; Montejo C; Pulido-Valdeolivas I; Alba-Arbalat S; Sola-Valls N; Sepúlveda M; Blanco Y; Saiz A; Radua J; Llufriu S
    Neuroimage Clin; 2020; 28():102411. PubMed ID: 32950904
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of diffusion tensor-based tractography and quantified brain atrophy for analyzing demyelination and axonal loss in MS.
    Fink F; Klein J; Lanz M; Mitrovics T; Lentschig M; Hahn HK; Hildebrandt H
    J Neuroimaging; 2010 Oct; 20(4):334-44. PubMed ID: 19453832
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging--evidence of Wallerian degeneration.
    Ciccarelli O; Werring DJ; Barker GJ; Griffin CM; Wheeler-Kingshott CA; Miller DH; Thompson AJ
    J Neurol; 2003 Mar; 250(3):287-92. PubMed ID: 12638018
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multi-modal quantitative MRI investigation of brain tissue neurodegeneration in multiple sclerosis.
    Hasan KM; Walimuni IS; Abid H; Wolinsky JS; Narayana PA
    J Magn Reson Imaging; 2012 Jun; 35(6):1300-11. PubMed ID: 22241681
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot study.
    Saraste M; Bezukladova S; Sucksdorff M; Saunavaara V; Rissanen E; Matilainen M; Airas L
    Mult Scler Relat Disord; 2021 Feb; 48():102690. PubMed ID: 33352357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation of cognitive dysfunction and diffusion tensor MRI measures in patients with mild and moderate multiple sclerosis.
    Van Hecke W; Nagels G; Leemans A; Vandervliet E; Sijbers J; Parizel PM
    J Magn Reson Imaging; 2010 Jun; 31(6):1492-8. PubMed ID: 20512905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.